Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2018
Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases
J Seoane, L De Mattos-Arruda, E Le Rhun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2005
Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer
M Moroni, A Sartore-Bianchi, S Benvenuti, et al.
Journal of Cellular Physiology
|
October 21, 1999
MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential
T A Williams, P Longati, L Pugliese, et al.
The Journal of Biological Chemistry
|
January 13, 1995
Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction
L Naldini, E Vigna, A Bardelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 1998
A point mutation in the MET oncogene abrogates metastasis without affecting transformation
S Giordano, A Bardelli, Z Zhen, et al.
Oncogene
|
February 13, 1997
Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2
D Besser, A Bardelli, S Didichenko, et al.
The EMBO Journal
|
November 15, 1996
HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
A Bardelli, P Longati, D Albero, et al.
Nature
|
January 24, 1998
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
C Boccaccio, M Andò, L Tamagnone, et al.
The Biochemical Journal
|
November 10, 1998
Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met
E Villa-Moruzzi, F Puntoni, A Bardelli, et al.
Oncogene
|
September 28, 1999
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
P Michieli, C Basilico, S Pennacchietti, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2018
Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases
J Seoane, L De Mattos-Arruda, E Le Rhun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2005
Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer
M Moroni, A Sartore-Bianchi, S Benvenuti, et al.
Journal of Cellular Physiology
|
October 21, 1999
MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential
T A Williams, P Longati, L Pugliese, et al.
The Journal of Biological Chemistry
|
January 13, 1995
Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction
L Naldini, E Vigna, A Bardelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 1998
A point mutation in the MET oncogene abrogates metastasis without affecting transformation
S Giordano, A Bardelli, Z Zhen, et al.
Oncogene
|
February 13, 1997
Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2
D Besser, A Bardelli, S Didichenko, et al.
The EMBO Journal
|
November 15, 1996
HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
A Bardelli, P Longati, D Albero, et al.
Nature
|
January 24, 1998
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
C Boccaccio, M Andò, L Tamagnone, et al.
The Biochemical Journal
|
November 10, 1998
Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met
E Villa-Moruzzi, F Puntoni, A Bardelli, et al.
Oncogene
|
September 28, 1999
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
P Michieli, C Basilico, S Pennacchietti, et al.
Page
of 6